ATR-258   Click here for help

GtoPdb Ligand ID: 14732

Synonyms: ATR258 | compound 15 [PMID: 40555230]
Compound class: Synthetic organic
Comment: ATR-258 is an orally bioavailable, orthosteric GRK-biased β2-adrenoceptor (β2-AR) agonist [1]. Experimental evidence reveals competitive β1-AR antagonist actions and weak partial β3-AR agonist activity. ATR-258 is intended to optimise β2AR-mediated muscular glucose uptake whilst reducing Gs/cAMP-driven cardiac side effects and β-arrestin-dependent desensitisation.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 3
Hydrogen bond donors 2
Rotatable bonds 4
Topological polar surface area 44.62
Molecular weight 212.26
XLogP 0.24
No. Lipinski's rules broken 0

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C)(C)NC[C@@H](C1=CN=CC(=C1)F)O
Isomeric SMILES FC1=CC([C@H](CNC(C)(C)C)O)=CN=C1
InChI InChI=1S/C11H17FN2O/c1-11(2,3)14-7-10(15)8-4-9(12)6-13-5-8/h4-6,10,14-15H,7H2,1-3H3/t10-/m0/s1
InChI Key SASMSPQPEDQJII-JTQLQIEISA-N

Generated using the Chemistry Development Kit (CDK) (Willighagen EL et al. Journal of Cheminformatics vol. 9:33. 2017, doi:10.1186/s13321-017-0220-4; https://cdk.github.io/)

No information available.
Summary of Clinical Use Click here for help
ATR-258 was progressed as a clinical candidate for the treatment of type 2 diabetes and obesity.
Clinical Trials
Clinical Trial ID Title Type Source Comment References
NCT07421024 Biased GRK Signaling Via β2-Adrenergic Receptors in Human Skeletal Muscle Phase 2 Interventional University of Copenhagen